FibroGen China Anemia Holdings, Ltd. — Form D/A
FibroGen China Anemia Holdings, Ltd. of GRAND CAYMAN, E9, a company, filed a Form D amendment with the SEC on 2013-01-14. $6.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-01-14
- Form: D/A
- Accession: 0001555069-13-000001
- Industry: Biotechnology
- Exemptions: 06
- Amount sold: $6.7M
- Minimum investment: $2K
- Investors: 53
- Date of first sale: 2012-07-11
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-181913
Issuer
- Name: FibroGen China Anemia Holdings, Ltd.
- CIK: 0001555069
- Entity type: Corporation
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2012
- Address: C/O OGIER FIDUCIARY SERVICES (CAYMAN)LTD, GRAND CAYMAN, E9, KY1-9007
- Phone: 4159781200
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| Thomas B Neff | Director | San Francisco, CA |
Other filings by this issuer (1)
More